Stem cell transplant, Product advertising issue, Wrong technique in product usage process +3
Drugs: STEM CELL, EXOSOME, OR GROWTH FACTOR DERIVED UNAPPROVED PRODUCTS
- Safetyreportversion
- 1
- Safetyreportid
- 25860238
- Primarysourcecountry
- US
- Transmissiondateformat
- 102
- Transmissiondate
- 20251021
- Reporttype
- 1
- Serious
- 1
- Seriousnessdeath
- 2
- Seriousnesslifethreatening
- 2
- Seriousnesshospitalization
- 2
- Seriousnessdisabling
- 2
- Seriousnesscongenitalanomali
- 2
- Seriousnessother
- 1
- Receivedateformat
- 102
- Receivedate
- 20250927
- Receiptdateformat
- 102
- Receiptdate
- 20250927
- Fulfillexpeditecriteria
- 3
- Authoritynumb
- FDA-CDER-CTU-2025-65042
- Primarysource
- Reportercountry
- US
- Qualification
- 3
- Sender
- Sendertype
- 6
- Senderorganization
- FDA-CTU
- Receiver
- Receivertype
- 6
- Receiverorganization
- FDA
- Patient
- Patientonsetage
- 74
- Patientonsetageunit
- 801
- Patientsex
- 2
- Reaction
- Reactionmeddraversionpt
- 28.0
- Reactionmeddrapt
- Stem cell transplant
- Reactionmeddraversionpt
- 28.0
- Reactionmeddrapt
- Product advertising issue
- Reactionmeddraversionpt
- 28.0
- Reactionmeddrapt
- Wrong technique in product usage process
- Reactionmeddraversionpt
- 28.0
- Reactionmeddrapt
- Drug monitoring procedure not performed
- Reactionmeddraversionpt
- 28.0
- Reactionmeddrapt
- Drug ineffective
- Reactionmeddraversionpt
- 28.0
- Reactionmeddrapt
- Victim of abuse
- Drug
- Drugcharacterization
- 1
- Medicinalproduct
- STEM CELL, EXOSOME, OR GROWTH FACTOR DERIVED UNAPPROVED PRODUCTS
- Activesubstance
- Activesubstancename
- STEM CELL, EXOSOME, OR GROWTH FACTOR DERIVED UNAPPROVED PRODUCTS
- Summary
- Narrativeincludeclinical
- CASE EVENT DATE: 20250528
